Company intelligence / Profile preview

Dascoli Pharma AG

Zürich, Zürich, Switzerlanddascoli-pharma.ch ↗

Ownership: Private
Development stage: Commercial

Overview

Dascoli Pharma distributes GMP-certified medical cannabis products and recently partnered with SOMAÍ Pharmaceuticals to introduce EU-GMP full-spectrum Essentials line extracts to the Swiss market

Modalities: Medical cannabis extracts
Industry: Non-Academic Healthcare

Partnerships

SOMAÍ Pharmaceuticals (announced February 25, 2025)

Beyond the preview

Go deeper on Dascoli Pharma AG.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dascoli Pharma AG.

Explore the full profile